Experimental induction of Proteus mirabilis cystitis in the pony and evaluation of therapy with trimethoprim-sulfadiazine.

This research involves an experiment that induced urinary tract infection (Proteus mirabilis cystitis) in ponies by first damaging the bladder lining, and then examined the effectiveness of a trimethoprim-sulfadiazine paste treatment.

Experimental Design

• The research team set out to induce Proteus mirabilis cystitis in ponies by chemically eroding the bladder mucosa (tissue lining the bladder) before introducing the bacteria responsible for the infection. This recreation of a clinical disease scenario allows for an in-depth understanding of the disease process and the evaluation of potential therapeutic interventions.
• The sample size for this experiment consisted of nine ponies. This generated enough data to allow for comparative analysis and meaningful interpretation of the results.

Treatment and Control Group Comparison

• The ponies were divided into groups: those treated with a trimethoprim-sulfadiazine (TMP-SDZ) paste for 13 days and positive and negative controls. This division allowed the researchers to gauge the effect and effectiveness of the TMP-SDZ treatment regimen.
• The TMP-SDZ paste is a combination antibiotic therapy often used for its broad-spectrum activity against many types of bacteria.

Observations and Outcomes

• Urine samples from the ponies were evaluated at various time points. Those treated with TMP-SDZ turned negative for the Proteus mirabilis infection between days 3 and 9 after treatment began, indicating the effectiveness of the TMP-SDZ paste.
• In contrast, the positive control group (ponies with the infection but without any treatment) remained infected until day 13, demonstrating the severity and course of the infection when left untreated.
• By day 28, urine samples from all ponies were negative for the Proteus mirabilis infection. This indicates that even without treatment, the ponies were eventually able to clear the infection, although it took considerably longer than with treatment.
• Urine concentrations of trimethoprim and sulfadiazine (the active components of the TMP-SDZ paste) were found to be relatively high on day 1 of the treatment, suggesting the antibiotic paste was absorbed and presented in the urine rapidly after administration.